# Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis

> **NCT07527572** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Kaneka Americas Holding Inc.** · enrollment: 160 (estimated)

## Conditions studied

- Vaginosis, Bacterial
- Bacterial Vaginosis
- Bacterial Vaginosis (BV)

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus gasseri KABP®064 10e9 CFU/capsule
- **DIETARY_SUPPLEMENT:** Placebo (maltodextrin)

## Key facts

- **NCT ID:** NCT07527572
- **Lead sponsor:** Kaneka Americas Holding Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07527572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07527572, "Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07527572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*